ArticleFrontiers in immunology2018

APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.

Daniela A Covino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.